The Center for Technology Licensing (CTL) is Cornell University's technology transfer office.
We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.
The FastTrack Startup License program was introduced in July 2018 for new ventures based on Cornell technologies in the fields of engineering and physical sciences. It’s an experimental approach to licensing startups, designed to enhance our pro-startup ecosystem at Cornell, and increase the transparency and speed of the licensing process. We are committed to continually evaluating and improving the program, with the goals to help increase the quality and quantity of technology startups and catalyze technology commercialization.
The FastTrack Startup license is a ‘ready to be executed’ agreement with favorable, balanced, and fixed terms. Minimal negotiation focuses on the field-of-use and due diligence from the Licensee in its commitment/milestones to commercialize the innovation.
There are menu options to choose from, designed to accommodate different types of businesses, from those geared towards VC funding, to those focused on strategic partnerships, to bootstrapped efforts.
NOT INCLUDED: therapeutics, diagnostics, agriculture, food, veterinary, software, medical devices
Any new startups based on Cornell technologies in the applicable fields, provided that the inventors agree with the path of new venture and the team selection.
To make sure that Cornell’s technologies are licensed to parties who have the capability and reasonable plans to develop the inventions to commercial products and services, CTL requires the startups to provide their business plans or similar materials to describe the following:
A viable team of founders/committed advisors for the startup
Value proposition for the market
We understand that business plans may evolve as companies grow and adapt to the market place, especially at the early stage development. When the startup is not ready to license the Cornell technology but has the promise to be a viable opportunity:
A simple 6-month option can be offered to the company with a low fee of $1000 (waived if the inventors are part of the founding team).
The option period can be extended for another 6-months for a low fee of $2500 at CTL’s discretion.
During the option period, the team is expected to work with regional incubators, accelerators, and/or other training programs to sharpen the business idea and connect to suitable resources.
Key financial terms for the Exclusive License
4% non-dilutable through subsequent equity financing aggregating $2 million
1% non-dilutable until Change of Control
2% of Net Sales* without Anti-Stacking term
3% of Net Sales* with Anti-Stacking term (potentially down to 1.5%)
Pass through royalty**, then 15% of other sublicense income
No pass through royalty**, then 25% of all sublicense income
(Creditable against royalties)
1-4 years: $0
5-6 years: $15K/year
Annual after: $40K/year
Reimbursement of all past Patent Expenses, plus the first $5,000 in future patent expenses, will be deferred up to 2 years.
(For any startup companies that elect to locate their principal operations in Tompkins County, NY, Cornell will increase the $5,000 to $20,000 and extend the 2 years to 3 years.)
* For products based on licensed Cornell technologies
** Pass Through Royalty means the sublicensee applies the same royalty rate to its Net Sales as the licensee